Anza Therapeutics


Public list: Smart Money VCs (6328) Pharma Startups (4732) Cancer Therapeutics (1137)

Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.

Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can...Show all

Company (Alive / Active)

Phone:

Fax:

150 Allens Creek Road

Concord, 14618
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Anza Therapeutics $18M Nov 6, 2007
See all 22 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Anza Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Humanetics Corporation

Minneapolis, Minnesota, United States
Alive / ActiveHumanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.Login to see details

GlobeImmune

Louisville, Colorado, United States
IPO / Went publicGlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to activate the immune system by stimulating cellular immunity, known as T cell immunity, in contrast to traditional vaccines that predominately stimulate antibody production. To date, Tarmogen product candidates have been generally well tolerated in clinical trials for multiple disease indications an...Show allLogin to see details
See all 22 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Marking cartridge Aug 11, 2013 Jul 07, 2015 Patent
Untitled Feb 06, 2004 Apr 06, 2010 Patent